Investor, Entrepreneur Steven Yecies Joins Mellitus Health Board

LOS ANGELES--(BUSINESS WIRE)-- Healthcare entrepreneur and investor Steven Yecies has joined the board of Mellitus Health, the company announced today. Mellitus Health’s decision support software, Insulin Insights™, delivers precision insulin prescription adjustment recommendations to clinicians for all types of insulin and all major regimens.

“For more than 25 years, Steven has pinpointed, funded and scaled transformative innovation in healthcare. We are thrilled to add his extraordinary expertise and insights to our board,” said Josh Davidson, CEO.

Yecies has moved at the forefront of meaningful clinical and process change in healthcare in the U.S. and in major European, Asian and Middle Eastern markets through leadership roles at numerous firms. Most recently, he started and led the venture investments in healthcare IT at OrbiMed Advisors, a premier global investor in healthcare. He previously founded his own investment firm, Chronic Health Capital, which focused on private equity investments in healthcare IT and services, and established the health and wellness business at Scient (NASDAQ: SCNT), where he built more than 40 first generation e-health businesses for national health systems and leading global healthcare enterprises.

Yecies holds an MBA from Harvard Business School; a JD from the University of California, Berkeley; and an AB from Dartmouth College.

“Management of diabetes is a big problem. Mellitus Health’s ability to adjust all insulin prescriptions in ways that significantly lower blood glucose, without incidents of dangerous hypoglycemia, is what drew me to the company. It’s the only firm I’ve seen that provides a universal solution and customizes insulin prescription recommendations for nearly every conceivable insulin combination,” Yecies commented.

“The best ideas in healthcare apply globally, with the ability to help patients both inside and outside the U.S., in the office or remotely. Mellitus Health’s software can help any insulin-using patient, anywhere. The telehealth potential is immense, as is its potential for use by physician extenders. It provides a tremendous clinical and administrative value proposition for enterprises, practices and patients.”

About Mellitus Health, Inc.

Building on 35 years of clinical research by past American Diabetes Association president Mayer B. Davidson, MD, Mellitus Health has automated—and expanded—the highly effective algorithm-based insulin dosing protocol that Dr. Davidson taught generations of clinicians. Its Insulin Insights™ software delivers insulin prescription adjustment recommendations to clinicians in seconds. Unique in the market, it can handle all insulins, every commonly used insulin regimen and virtually every dosing scenario.

Learn more at www.MellitusHealth.com.

 

Contacts

Mellitus Health, Inc.
Josh Davidson, 424-218-0792
CEO

 

 
 

Source: Mellitus Health, Inc.

Back to news